Neumora Therapeutics, Inc. Common Stock (NMRA) Analyst Forecast

$2.28

south_east
-$0.14 (-5.79%)
Day's range
$2.16
Day's range
$2.38

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
01/02/2025 RBC Capital Brian Abrahams $4.00 $1.97   103.05%
07/22/2024 Needham Ami Fadia $23.00 $11.28   103.9%
07/08/2024 Mizuho Securities Graig Suvannavejh $20.00 $10.25   95.12%
06/17/2024 RBC Capital Brian Abrahams $29.00 $9.71   198.66%
03/13/2024 RBC Capital Brian Abrahams $31.00 $14.81   109.32%
10/10/2023 Stifel Nicolaus Paul Matteis $26.00 $10.91   138.31%
10/10/2023 RBC Capital Brian Abrahams $24.00 $10.91   119.98%

Neumora Therapeutics, Inc. Common Stock FAQ's

What analysts cover Neumora Therapeutics, Inc. Common Stock?

Neumora Therapeutics, Inc. Common Stock has been rated by research analysts at RBC Capital, Needham, Mizuho Securities, Stifel Nicolaus in the past 90 days.